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Abstract
Andrographolide is important material present in Andrographis paniculata. This material can promote T cell to 
develop into regulatory T cell, CD4+CD25+. CD4+CD25+ regulatory T (Treg) cells, a component of the innate 
immune response, which play a key role in the maintenance of self-tolerance, have become the focus of 
numerous studies over the last decade. These cells have the potential to be exploited to treat autoimmune disease. 
These cells inhibit the immune response in an Ag-nonspecific manner, interacting with other T cells. These T cell 
populations actively control the properties of other immune cells by suppressing their functional activity to 
prevent autoimmunity but also influence the immune response to allergens as well as against tumor cells and 
pathogens. In this experiment we showed that active compound from Andrographis paniculata namely 
andrographolide can induce active regulatory T cell that has an efficacy to cure rheumatoid arthritis mice model.
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Introduction
Andrographolide is the main labdane 
diterpene present in Andrographis paniculata. Two 
lines of evidence report immunostimulant and 
anti-inflammatory properties for 
andrographolide in different models. In the 
other hand is known that CD4+CD25+
regulatory T cells can protect an individual from 
autoimmune diseases. There is some evidence 
that CD4+CD25+ regulatory T cells have an 
ability to prevent the development of 
autoreactive cells. In human, CD8+CXCR3+
cells are believed to be a regulatory T cells that 
has the same ability with CD4+CD25+ in mice 
[1-5, 10, 19].  
Rheumatoid arthritis (RA) is a chronic 
inflammatory disorder that ultimately leads to 
the destruction of joint architecture. The 
pathogenic events that lead to the development 
of RA are not fully understood, although the 
presence of inflammatory cytokines has been 
well  documented  to play   a key role  in  the
induction and maintenance of this disease [16-
21]. This disease attacked around 1% population 
of the world that appear in people in the aged of 
25-50 years, but did not close the possibility that 
people in any ages can suffer that disease. 
Rheumatoid arthritis is a degenerative disease 
that mostly attacks women. It is thought that 
various factors including genetic elements have a 
significant contribution to the emergence of this 
disease. 
Molecular structure of andrographolide
Rheumatoid arthritis treatment is usually 
done by resting the affected joint and consumes 
synthetic drugs. Treatment is often only relieve 
pain and prevent inflammation. Drugs that have 
been used for pain relieve and prevention of 
inflammation is non-steroidal drug, anti-
inflammatory (aspirin and ibuprofen), slow-
acting drugs, penicillamine, corticosteroids, and 
immunosuppressive drugs. The use of these 
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drugs in the long term will be very harmful and 
cause various side effects that involve almost 
every organ [6-18, 20, 21]. Because of serious 
impacts resulting from the rheumatoid arthritis 
treatment, it is necessary to include prevention 
efforts that can normalize cell homeostasis. In 
this study we tested herbs that rich 
andrographolide, the material containing active 
compound to induce regulatory T cells.
Materials and methods
Mice was intravenously injected with CFA 
(complete Freund's adjuvant) of 75 μl, then 
performed a second booster in mice feet by 75 
μl (each leg of 35.5 μl). Observations were made 
every day to see the swelling of the feet. This 
treated mice is used as a model of rheumatoid 
arthritis (RA). Mice model of RA are 
intraperitoneally injected with 100μl or 400μl 
substrate of Andrographis paniculata that contain 
andrographolide.
Result and Discussion
Andrographolide derived from Andrographis 
paniculata is a medicinal compound which can 
stimuli the expression of CD25 molecules on T 
cells. CD25 molecule expression on CD4 T cells 
is one marker of the cell with the nature of the 
regulatory function. In RA mice the number of 
regulatory T cells is increased but cannot 
overcome the disease. Intrapetoneally injection 
of andrographolide (100μl and 400μl) isolated 
from Andrographis paniculata can increase the 
number of regulatory T cells dramatically (Figure. 
1). 
Intraperitoneally injection of 
andrographolide compound in RA mice model 
can ameliorate the disease and do not affect the 
ratio of limfoid cell signifantly. In this 
experiment we clearly showed that T cells which 
is analized from spleen looks normal in when 
treated with andrographolide (100μl and 400μl). 
This meant that andrographolide compound 
have an efficacy to cure RA mice model without 
interfering T cell condition (Figure. 2). After we 
know that the number of T cell lymphocytes do 
not  affected  by  the treatment we examine 
Figure 1. CD4+CD25+ cells increased in RA mice that 
received injections of andrographolide derived from 
Andrographis paniculata  substrate (100μl and 400μl). The 
bars are calculation of the number of CD4 T cells expressing 
positive CD25 molecules on the spleen cells of mice that had been 
injected with andrographolide (100μl and 400μl) derived from 
Andrographis paniculata. Analysis was carried out seven weeks post 
treatment. The two first bars on the left are controls for 
comparison. Data are mean ± SD values of three independent 
experiments (P<0.01).
Figure 2. The presence andrographolide do not interfere with 
homeostasis in mice. Spleen cells is labeled with anti-CD4-FITC 
and anti-CD8-PE antibodies. Adding andrographolide material 
compound isolated from Andrographis paniculata (100μl and 400μl) 
in mice does not affect the amount of CD4+ and CD8+ T cells in 
RA mice models. Upper left  panel (Nor = normal individuals), 
and the upper right panel (RA = rheumatoid arthritis  models).  
Data are representative of three independent experiment.
the status of these cells. The data showed that 
ameliorated mice by andrographo lide 
compound are associated with an increased 
number of naïve T cells marked with CD62L 
(Figue 3). RA mice model showed the decrease 
of naïve T cells. This naïve T cells increase when 
andrographolide material compound is 
intraperitoneally injected. From the emerged 
data can be explained that RA model mice rich 
memory and activated cell that disturb the mice 
health. 
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Figure 3. The expression of CD62L is decreased in mice 
model of RA. Spleen cell was obtained from RA mice seven 
weeks after treated with andrographolide derived from Andrographis 
paniculata. Upper left panel is a control that shows the expression 
of CD4+CD62L+ molecules and the right panel showed the 
decreased level of CD4+CD62L+ in RA mice model. Injection of 
andrographolide (100μl and 400μl) were shown at the bottom left 
and right panel,  respectively. Data are representative of three 
independent experiments.
Figure 4. Mice with rheumatoid arthritis (RA) experienced 
swelling in the joints. The first bar is normal control. Second bar 
is RA mice model without treatment and other bars are RA model 
mice treated with andrographolide derived from Andrographis 
paniculata. (100μl and 400μl). This experiment shows that RA mice 
feet have swollen twice larger compared with normal mice. 
Injection of andrographolide can cure RA mice become normal 
phenotype. Data are mean ± SD values of three independent 
experiments (P<0.01).
In this study, swelling of the soles of the feet 
is measured by measuring the increase of foot 
volume or inflammation. In this experiment we 
found that injection of andrographolide derived 
from Andrographis paniculata can improve the 
health condition of RA mice model. RA mice 
model shows swollen legs and this condition can 
be overcome by injection of andrographolide 
derived from Andrographis paniculata (Figure 4). 
To test whether andrographolide has a toxic 
effect on the treated mice, we conducted 
bioassays by measuring the weight of each 
treatment compared with control. In this study, 
the data indicate that the dose of 100μl and 
400μl is a safe dose. Injection at 100μl and 400μl 
shows no physiological disorder that remained 
normal weight mice. Similarly, the observation 
of liver cells (unpublished data) showed no toxic 
effect on treatment with andrographolide 
(Figure 5).
Figure 5. Andrographolide does not show toxic effects in 
animal models of RA. The body weight of mice are measured 7 
weeks after treatment.  Data are mean ± SD values of three 
independent experiments (P<0.01).
Conclussion
Andrographolide which is exist in 
Andrographis paniculata has significant benefits for 
increasing the number of sets of CD4+CD25+
regulatory T cells. Increased CD4+CD25+
regulatory T cells will help to cure rheumatoid 
arthritis. In mice model of rheumatoid arthritis, 
CD4+CD25+ regulatory T cell play important 
role to inhibit the development of effectors T 
cells and prevent the development of 
inflammation in the joints. The generation of 
CD4+CD25+ regulatory can be induced by 
intraperitoneal injection with andrographolide. 
Induced CD4+CD25+ regulatory T cell can 
ameliorate mice model of rheumatoid arthritis. 
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